Global Hepatitis C Drug Market Professional Survey Report 2017

July 2017 | 105 pages | ID: GF1EA89B5AFEN
QYResearch

Abstracts

This report studies Hepatitis C Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Merck & Co
• Kenilworth
• Roche
• Basel GlaxoSmith
• Gilead Sciences
• AbbVie
• Johnson & Johnson
• Bristol-Myers Squibb

By types, the market can be split into

• Oral
• Injection
• Other

By Application, the market can be split into

• Hospitals
• Private Labs
• Physician Offices
• Public Health Labs
• Blood Bank

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

Contents

Global Hepatitis C Drug Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF HEPATITIS C DRUG

1.1 Definition and Specifications of Hepatitis C Drug
  1.1.1 Definition of Hepatitis C Drug
  1.1.2 Specifications of Hepatitis C Drug
1.2 Classification of Hepatitis C Drug
  1.2.1 Oral
  1.2.2 Injection
  1.2.3 Other
1.3 Applications of Hepatitis C Drug
  1.3.1 Hospitals
  1.3.2 Private Labs
  1.3.3 Physician Offices
  1.3.4 Public Health Labs
  1.3.5 Blood Bank
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF HEPATITIS C DRUG

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Hepatitis C Drug
2.3 Manufacturing Process Analysis of Hepatitis C Drug
2.4 Industry Chain Structure of Hepatitis C Drug

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF HEPATITIS C DRUG

3.1 Capacity and Commercial Production Date of Global Hepatitis C Drug Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Hepatitis C Drug Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Hepatitis C Drug Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Hepatitis C Drug Major Manufacturers in 2016

4 GLOBAL HEPATITIS C DRUG OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Hepatitis C Drug Capacity and Growth Rate Analysis
  4.2.2 2016 Hepatitis C Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Hepatitis C Drug Sales and Growth Rate Analysis
  4.3.2 2016 Hepatitis C Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Hepatitis C Drug Sales Price
  4.4.2 2016 Hepatitis C Drug Sales Price Analysis (Company Segment)

5 HEPATITIS C DRUG REGIONAL MARKET ANALYSIS

5.1 North America Hepatitis C Drug Market Analysis
  5.1.1 North America Hepatitis C Drug Market Overview
  5.1.2 North America 2012-2017E Hepatitis C Drug Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Hepatitis C Drug Sales Price Analysis
  5.1.4 North America 2016 Hepatitis C Drug Market Share Analysis
5.2 China Hepatitis C Drug Market Analysis
  5.2.1 China Hepatitis C Drug Market Overview
  5.2.2 China 2012-2017E Hepatitis C Drug Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Hepatitis C Drug Sales Price Analysis
  5.2.4 China 2016 Hepatitis C Drug Market Share Analysis
5.3 Europe Hepatitis C Drug Market Analysis
  5.3.1 Europe Hepatitis C Drug Market Overview
  5.3.2 Europe 2012-2017E Hepatitis C Drug Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Hepatitis C Drug Sales Price Analysis
  5.3.4 Europe 2016 Hepatitis C Drug Market Share Analysis
5.4 Southeast Asia Hepatitis C Drug Market Analysis
  5.4.1 Southeast Asia Hepatitis C Drug Market Overview
  5.4.2 Southeast Asia 2012-2017E Hepatitis C Drug Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Hepatitis C Drug Sales Price Analysis
  5.4.4 Southeast Asia 2016 Hepatitis C Drug Market Share Analysis
5.5 Japan Hepatitis C Drug Market Analysis
  5.5.1 Japan Hepatitis C Drug Market Overview
  5.5.2 Japan 2012-2017E Hepatitis C Drug Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Hepatitis C Drug Sales Price Analysis
  5.5.4 Japan 2016 Hepatitis C Drug Market Share Analysis
5.6 India Hepatitis C Drug Market Analysis
  5.6.1 India Hepatitis C Drug Market Overview
  5.6.2 India 2012-2017E Hepatitis C Drug Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Hepatitis C Drug Sales Price Analysis
  5.6.4 India 2016 Hepatitis C Drug Market Share Analysis

6 GLOBAL 2012-2017E HEPATITIS C DRUG SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Hepatitis C Drug Sales by Type
6.2 Different Types of Hepatitis C Drug Product Interview Price Analysis
6.3 Different Types of Hepatitis C Drug Product Driving Factors Analysis
  6.3.1 Oral of Hepatitis C Drug Growth Driving Factor Analysis
  6.3.2 Injection of Hepatitis C Drug Growth Driving Factor Analysis
  6.3.3 Other of Hepatitis C Drug Growth Driving Factor Analysis

7 GLOBAL 2012-2017E HEPATITIS C DRUG SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Hepatitis C Drug Consumption by Application
7.2 Different Application of Hepatitis C Drug Product Interview Price Analysis
7.3 Different Application of Hepatitis C Drug Product Driving Factors Analysis
  7.3.1 Hospitals of Hepatitis C Drug Growth Driving Factor Analysis
  7.3.2 Private Labs of Hepatitis C Drug Growth Driving Factor Analysis
  7.3.3 Physician Offices of Hepatitis C Drug Growth Driving Factor Analysis
  7.3.4 Public Health Labs of Hepatitis C Drug Growth Driving Factor Analysis
  7.3.5 Blood Bank of Hepatitis C Drug Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF HEPATITIS C DRUG

8.1 Merck & Co
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Merck & Co 2016 Hepatitis C Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Merck & Co 2016 Hepatitis C Drug Business Region Distribution Analysis
8.2 Kenilworth
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Kenilworth 2016 Hepatitis C Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Kenilworth 2016 Hepatitis C Drug Business Region Distribution Analysis
8.3 Roche
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Roche 2016 Hepatitis C Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Roche 2016 Hepatitis C Drug Business Region Distribution Analysis
8.4 Basel GlaxoSmith
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Basel GlaxoSmith 2016 Hepatitis C Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Basel GlaxoSmith 2016 Hepatitis C Drug Business Region Distribution Analysis
8.5 Gilead Sciences
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Gilead Sciences 2016 Hepatitis C Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Gilead Sciences 2016 Hepatitis C Drug Business Region Distribution Analysis
8.6 AbbVie
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 AbbVie 2016 Hepatitis C Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 AbbVie 2016 Hepatitis C Drug Business Region Distribution Analysis
8.7 Johnson & Johnson
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Johnson & Johnson 2016 Hepatitis C Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Johnson & Johnson 2016 Hepatitis C Drug Business Region Distribution Analysis
8.8 Bristol-Myers Squibb
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Bristol-Myers Squibb 2016 Hepatitis C Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Bristol-Myers Squibb 2016 Hepatitis C Drug Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF HEPATITIS C DRUG MARKET

9.1 Global Hepatitis C Drug Market Trend Analysis
  9.1.1 Global 2017-2022 Hepatitis C Drug Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Hepatitis C Drug Sales Price Forecast
9.2 Hepatitis C Drug Regional Market Trend
  9.2.1 North America 2017-2022 Hepatitis C Drug Consumption Forecast
  9.2.2 China 2017-2022 Hepatitis C Drug Consumption Forecast
  9.2.3 Europe 2017-2022 Hepatitis C Drug Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Hepatitis C Drug Consumption Forecast
  9.2.5 Japan 2017-2022 Hepatitis C Drug Consumption Forecast
  9.2.6 India 2017-2022 Hepatitis C Drug Consumption Forecast
9.3 Hepatitis C Drug Market Trend (Product Type)
9.4 Hepatitis C Drug Market Trend (Application)

10 HEPATITIS C DRUG MARKETING TYPE ANALYSIS

10.1 Hepatitis C Drug Regional Marketing Type Analysis
10.2 Hepatitis C Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Hepatitis C Drug by Region
10.4 Hepatitis C Drug Supply Chain Analysis

11 CONSUMERS ANALYSIS OF HEPATITIS C DRUG

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL HEPATITIS C DRUG MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Hepatitis C Drug
Table Product Specifications of Hepatitis C Drug
Table Classification of Hepatitis C Drug
Figure Global Production Market Share of Hepatitis C Drug by Type in 2016
Figure Oral Picture
Table Major Manufacturers of Oral
Figure Injection Picture
Table Major Manufacturers of Injection
Figure Other Picture
Table Major Manufacturers of Other
Table Applications of Hepatitis C Drug
Figure Global Consumption Volume Market Share of Hepatitis C Drug by Application in 2016
Figure Hospitals Examples
Table Major Consumers of Hospitals
Figure Private Labs Examples
Table Major Consumers of Private Labs
Figure Physician Offices Examples
Table Major Consumers of Physician Offices
Figure Public Health Labs Examples
Table Major Consumers of Public Health Labs
Figure Blood Bank Examples
Table Major Consumers of Blood Bank
Figure Market Share of Hepatitis C Drug by Regions
Figure North America Hepatitis C Drug Market Size (Million USD) (2012-2022)
Figure China Hepatitis C Drug Market Size (Million USD) (2012-2022)
Figure Europe Hepatitis C Drug Market Size (Million USD) (2012-2022)
Figure Southeast Asia Hepatitis C Drug Market Size (Million USD) (2012-2022)
Figure Japan Hepatitis C Drug Market Size (Million USD) (2012-2022)
Figure India Hepatitis C Drug Market Size (Million USD) (2012-2022)
Table Hepatitis C Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Hepatitis C Drug in 2016
Figure Manufacturing Process Analysis of Hepatitis C Drug
Figure Industry Chain Structure of Hepatitis C Drug
Table Capacity and Commercial Production Date of Global Hepatitis C Drug Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Hepatitis C Drug Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Hepatitis C Drug Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Hepatitis C Drug Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Hepatitis C Drug 2012-2017
Figure Global 2012-2017E Hepatitis C Drug Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Hepatitis C Drug Market Size (Value) and Growth Rate
Table 2012-2017E Global Hepatitis C Drug Capacity and Growth Rate
Table 2016 Global Hepatitis C Drug Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Hepatitis C Drug Sales (K Units) and Growth Rate
Table 2016 Global Hepatitis C Drug Sales (K Units) List (Company Segment)
Table 2012-2017E Global Hepatitis C Drug Sales Price (USD/Unit)
Table 2016 Global Hepatitis C Drug Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Hepatitis C Drug 2012-2017E
Figure North America 2012-2017E Hepatitis C Drug Sales Price (USD/Unit)
Figure North America 2016 Hepatitis C Drug Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Hepatitis C Drug 2012-2017E
Figure China 2012-2017E Hepatitis C Drug Sales Price (USD/Unit)
Figure China 2016 Hepatitis C Drug Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Hepatitis C Drug 2012-2017E
Figure Europe 2012-2017E Hepatitis C Drug Sales Price (USD/Unit)
Figure Europe 2016 Hepatitis C Drug Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Hepatitis C Drug 2012-2017E
Figure Southeast Asia 2012-2017E Hepatitis C Drug Sales Price (USD/Unit)
Figure Southeast Asia 2016 Hepatitis C Drug Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Hepatitis C Drug 2012-2017E
Figure Japan 2012-2017E Hepatitis C Drug Sales Price (USD/Unit)
Figure Japan 2016 Hepatitis C Drug Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Hepatitis C Drug 2012-2017E
Figure India 2012-2017E Hepatitis C Drug Sales Price (USD/Unit)
Figure India 2016 Hepatitis C Drug Sales Market Share
Table Global 2012-2017E Hepatitis C Drug Sales (K Units) by Type
Table Different Types Hepatitis C Drug Product Interview Price
Table Global 2012-2017E Hepatitis C Drug Sales (K Units) by Application
Table Different Application Hepatitis C Drug Product Interview Price
Table Merck & Co Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck & Co Hepatitis C Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Merck & Co Hepatitis C Drug Business Region Distribution
Table Kenilworth Information List
Table Product A Overview
Table Product B Overview
Table 2016 Kenilworth Hepatitis C Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Kenilworth Hepatitis C Drug Business Region Distribution
Table Roche Information List
Table Product A Overview
Table Product B Overview
Table 2015 Roche Hepatitis C Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Roche Hepatitis C Drug Business Region Distribution
Table Basel GlaxoSmith Information List
Table Product A Overview
Table Product B Overview
Table 2016 Basel GlaxoSmith Hepatitis C Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Basel GlaxoSmith Hepatitis C Drug Business Region Distribution
Table Gilead Sciences Information List
Table Product A Overview
Table Product B Overview
Table 2016 Gilead Sciences Hepatitis C Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Gilead Sciences Hepatitis C Drug Business Region Distribution
Table AbbVie Information List
Table Product A Overview
Table Product B Overview
Table 2016 AbbVie Hepatitis C Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 AbbVie Hepatitis C Drug Business Region Distribution
Table Johnson & Johnson Information List
Table Product A Overview
Table Product B Overview
Table 2016 Johnson & Johnson Hepatitis C Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Johnson & Johnson Hepatitis C Drug Business Region Distribution
Table Bristol-Myers Squibb Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bristol-Myers Squibb Hepatitis C Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Bristol-Myers Squibb Hepatitis C Drug Business Region Distribution
Figure Global 2017-2022 Hepatitis C Drug Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Hepatitis C Drug Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Hepatitis C Drug Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Hepatitis C Drug Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Hepatitis C Drug Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Hepatitis C Drug Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Hepatitis C Drug Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Hepatitis C Drug Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Hepatitis C Drug Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Hepatitis C Drug by Type 2017-2022
Table Global Consumption Volume (K Units) of Hepatitis C Drug by Application 2017-2022
Table Traders or Distributors with Contact Information of Hepatitis C Drug by Region